Beneficient (BENF) Stock Price & Analysis
Beneficient (BENF) fell 8.19% to USD 3.25 as of July 25, 2026 at 09:56 UTC, according to Nexqual real-time market data.
BENF last closed at USD 3.54; the session ranged USD 3.21–3.5 on volume of 12,092 shares. Market capitalization is $47.09M, with a 52-week range of USD 2.16–12.48 (NCM). Source: Nexqual, July 25, 2026 at 09:56 UTC.
Key Statistics (as of July 25, 2026 at 09:56 UTC)
| Price | USD 3.25 |
|---|---|
| Change | ▼ 8.19% (down) |
| Previous Close | USD 3.54 |
| Open | USD 3.34 |
| Day Range | USD 3.21 – 3.5 |
| 52-Week Range | USD 2.16 – 12.48 |
| Volume | 12,092 shares |
| Market Cap | $47.09M |
| Exchange | NCM |
Technical Analysis (BENF)
Nexqual's technical model rates BENF "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 09:56 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 43.8 (neutral) |
| vs SMA50 | Below (USD 3.49) |
| MACD | -0.04 (negative) |
Analyst Ratings (BENF)
Wall Street analysts rate BENF "Strong Buy" based on 1 analysts, with a mean price target of USD 10 (range USD 10–10), per Nexqual as of July 25, 2026 at 09:56 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 10 |
| High Target | USD 10 |
| Low Target | USD 10 |
| Buy / Hold / Sell | 0 / 0 / 0 |
Earnings (BENF)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -3.72 vs est 0.07 ▼ miss |
| 2025-12-31 | USD 0.04 vs est 0 ▲ beat |
| 2025-09-30 | USD -2.96 vs est 3.04 ▼ miss |
| 2025-06-30 | USD -57.52 vs est 8.8 ▼ miss |
Source: Nexqual, July 25, 2026 at 09:56 UTC.
Financials & Fundamentals (BENF)
| Total Revenue | $90.14M |
|---|---|
| Revenue Growth (YoY) | +73.40% |
| Gross Margin | +95.94% |
| Operating Margin | +67.87% |
| Profit Margin | -6.25% |
| ROE | -14.91% |
| Debt / Equity | 486.17 |
| Current Ratio | 12.11 |
| Total Cash | $154.38M |
| Total Debt | $1.27B |
| Free Cash Flow | $421.32M |
Source: Nexqual, July 25, 2026 at 09:56 UTC.
Financial Health Score (BENF)
Nexqual rates Beneficient's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 09:56 UTC.
| Growth | Strong — Revenue +73% YoY (latest Q) |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Weak — $154M cash vs $1.27B debt |
| Cash Flow | Solid — Operating cash flow $12M |
| Efficiency | Critical — ROE -15%, ROA 1.7% |
Ownership (BENF)
| Insider Ownership | +90.93% |
|---|---|
| Institutional Ownership | +3.88% |
| Shares Outstanding | 14.49M |
| Short % of Float | +12.07% |
Source: Nexqual, July 25, 2026 at 09:56 UTC.
Leadership (BENF)
Beneficient is led by James G. Silk (age 56), Chief Executive Officer, per Nexqual as of July 25, 2026 at 09:56 UTC.
| Chief Executive Officer | James G. Silk (age 56) |
|---|---|
| Chief Financial Officer | Gregory W. Ezell (age 49) |
| President of BFF, Chief Fiduciary Officer & Director | Derek L. Fletcher (age 56) |
| Chief Technology Officer | Maria S. Rutledge (age 48) |
| Director of Communication | Dan Callahan |
Major Backers & Investors (BENF)
Notable institutional backers of Beneficient include Fidelity, Morgan Stanley, according to Nexqual as of July 25, 2026 at 09:56 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 0.84% |
| Morgan Stanley | 0.17% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.63% |
| Geode Capital | 1.09% |
| State Street | 0.36% |
| BlackRock | 0.31% |
| Northern Trust | 0.22% |
Source: Nexqual, July 25, 2026 at 09:56 UTC.
From Beneficient's Latest SEC 10-K Filing (filed 2026-06-30)
Key Strengths & Strategy (as disclosed to the SEC)
- While Ben's financial products and services are presently primarily offered through Ben Liquidity and Ben Custody, Ben plans to expand its capabilities under Ben Custody and provide additional products and services through Ben Insurance, L.L.C. and its subsidiaries (collectively, "Ben Insurance Services") and Ben Markets L.L.C., including its subsidiaries ("Ben Markets") in the future.
- Ben Insurance Services plans to provide insurance products and services to certain "affiliates" (as defined in the Kansas Captive Insurance Act), including the Customer ExAlt Trusts, custody accounts and other trusts for which BFF serves as trustee or custodian, to cover risks attendant to the ownership, management and transfer of alternative assets and financings related to alternative asset transactions.
- The AltAccess platform is designed to ultimately be provided through a software as a service ("SaaS") model to multiple intermediaries, including commercial lenders, and to be accessed through an application programming interface ("API") for these intermediaries to deploy in their businesses.
- Ben's internal technology team programmed in the flexibility to allow Ben to deliver the AltAccess platform using a software as a SaaS provider model to multiple intermediaries who could source Customers and transactions for Ben to process through API options as a white label platform for these intermediaries to also deploy in their businesses.
Partnerships
- In order to achieve an optimized risk adjusted return and diversification under our OptimumAlt endowment model, operational economies of scale, improved margins and tangible book value for our shareholders, the Board has approved the launch of a plan (the "ExchangeTrust Product Plan") to complete up to $5 billion of fiduciary financings to Customer ExAlt Trusts through ExchangeTrust transactions.
- Further, as fund sponsors continue to launch new products and face an increasingly competitive and challenging fund-raising environment, Ben estimates the potential demand for primary commitments to meet fundraising needs, which we can finance from our balance sheet, to be up to $330 billion 5 .
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VCIG | VCI Global Limited | USD 0.51 | ▼ 24.83% |
| NIVF | NewGenIvf Group Limited | USD 1.1 | ▼ 13.39% |
| TGL | Treasure Global Inc. | USD 3.06 | ▼ 6.42% |
| VSEE | VSee Health, Inc. | USD 0.08 | ▼ 1.25% |
| FRGT | Freight Technologies, Inc. | USD 3.01 | ▼ 15.45% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 09:56 UTC. This page is informational and not investment advice.